Drugs Made In America Acquisition (DMAA) Non Operating Income (2025)
Drugs Made In America Acquisition (DMAA) reported Non Operating Income of $2.3 million for Q4 2025, down 5.96% quarter-over-quarter from $2.4 million in Q3 2025.
Drugs Made In America Acquisition (DMAA) Non Operating Income (2025) Analysis & Trends
Drugs Made In America Acquisition has reported Non Operating Income for 1 years, with the latest figure at $2.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 4.31 Mn |
| 2 | Berto Acquisition | 312.46 Mn | 312.46 Mn | - | - |
| 3 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | 2.72 Mn |
| 4 | GP-Act III Acquisition | 311.36 Mn | 311.36 Mn | - | 2.98 Mn |
| 5 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | 2.65 Mn |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | - |
| 7 | Bold Eagle Acquisition | 275.54 Mn | 275.54 Mn | - | 2.37 Mn |
| 8 | Soulpower Acquisition | 264.91 Mn | 264.91 Mn | - | - |
| 9 | BTC Development | 262.16 Mn | 262.16 Mn | - | - |
| 10 | Drugs Made In America Acquisition | 223.11 Mn | 223.11 Mn | - | 2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.30 Mn |
| Sep 30, 2025 | 2.45 Mn |
| Jun 30, 2025 | 2.42 Mn |